IL6 and COVID-19: Early detection of αEp9 Abs in patients could be used to triage and treat COVID-19 prior to the onset of its most severe symptoms; delayed treatments with IL-6-targeting drugs can decrease their efficacy or be counterproductive (31, 37, –, 42) (Fig. 5B).